Search Results | Blood | American Society of Hematology

1-20 of 121

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

TaeHyung Kim, Joon Ho Moon, Jae-Sook Ahn, Yeo-Kyeoung Kim, Seung-Shin Lee, Seo-Yeon Ahn, Sung-Hoon Jung, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Ja-yeon Lee, Marc S. Tyndel, Myung-Geun Shin, Yoo Jin Lee, Sang Kyun Sohn, Seong-Kyu Park, Zhaolei Zhang, Hyeoung-Joon Kim, Dennis Dong Hwan Kim

Blood (2018) 132 (15): 1604–1613.

DOI: https://doi.org/10.1182/blood-2018-04-848028

Published: 2018

Includes: Supplemental data

Journal Articles

Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, Marc S. Tyndel, Yeo-Kyeoung Kim, Seung-Shin Lee, MD, Seo-Yeon Ahn, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Myung-Geun Shin, MD PhD, Hoon Kook, MD PhD, Sun-Hee Kim, MD, Seong Kyu Park, MD, Hyeoung-Joon Kim, Zhaolei Zhang, PhD, Dennis (Dong-Hwong) Kim, MD PhD

Blood (2017) 130 (Supplement 1): 271.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.271.271

Published: 2017

Journal Articles

Dynamics of Methylation Profiling in Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Shun Liao, Taehyung Kim, MSc, Hyeoung-Joon Kim, Jae-Sook Ahn, Jaehyuk Choi, Yeo-Kyeoung Kim, Yoon-Sang Kim, Seung-Shin Lee, MD, Zhaolei Zhang, PhD, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 1599.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1599.1599

Published: 2017

Journal Articles

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Seo-Yeon Ahn, Seong Young Kwon, Young Rok Do, MD PhD, Sung-Hoon Jung, MD, Jae-Sook Ahn, Yeo-Kyeoung Kim, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, Su Woong Yoo, Jung-Joon Min, Deok-Hwan Yang, MD PhD

Blood (2017) 130 (Supplement 1): 1546.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1546.1546

Published: 2017

Journal Articles

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, Marc S. Tyndel, Yeo-Kyeoung Kim, Seung-Shin Lee, MD, Seo-Yeon Ahn, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Yoojin Lee, MD, Sang Kyun Sohn, MDPhD, Yoo Hong Min, MD PhD, June-Won Cheong, MDPhD, Hyeoung-Joon Kim, Zhaolei Zhang, PhD, Dennis (Dong-Hwong) Kim, MD PhD

Blood (2017) 130 (Supplement 1): 3955.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3955.3955

Published: 2017

Journal Articles

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Blood (2017) 130 (Supplement 1): 5075.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5075.5075

Published: 2017

Journal Articles

Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma

Sung-Hoon Jung, MD, Seo-Yeon Ahn, Seung-Shin Lee, MD, Jae-Sook Ahn, Deok-Hwan Yang, MD PhD, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee, MD PhD

Blood (2017) 130 (Supplement 1): 5456.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.5456.5456

Published: 2017

Journal Articles

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

TaeHyung Kim, Marc S. Tyndel, Hyeoung Joon Kim, Jae-Sook Ahn, Seung Hyun Choi, Hee Jeong Park, Yeo-kyeoung Kim, Soo Young Kim, Jeffrey H. Lipton, Zhaolei Zhang, Dennis (Dong Hwan) Kim

Blood (2017) 129 (1): 38–47.

DOI: https://doi.org/10.1182/blood-2016-04-708560

Published: 2017

Includes: Supplemental data

Journal Articles

Prognostic Value of NCCN-IPI and Interim PET/CT Based on Visual Assessment in the Treatment of Peripheral T Cell Lymphomas

Seo-Yeon Ahn, Ho-Young Yhim, Young Rok Do, Sung-Hoon Jung, Jae-Sook Ahn, Yeo-Kyeoung Kim, Jung-Joon Min, Jae-Yong Kwak, Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang

Blood (2016) 128 (22): 1822.

DOI: https://doi.org/10.1182/blood.V128.22.1822.1822

Published: 2016

Journal Articles

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Blood (2016) 128 (22): 2876.

DOI: https://doi.org/10.1182/blood.V128.22.2876.2876

Published: 2016

Journal Articles

Aside from the Allelic Burden of JAK2 -V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML

Meong Hi Son, MD, Taehyung Kim, MSc, Jae-Sook Ahn, Marc Tyndel, Hyeoung-Joon Kim, Yeo-Kyeoung Kim, MD PhD, Seung-Shin Lee, Seo-Yeon Ahn, Sung-Hoon Jung, Deok-Hwan Yang, MD, Je-Jung Lee, Hee Jeong Park, Seung Hyun Choi, PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4281.

DOI: https://doi.org/10.1182/blood.V128.22.4281.4281

Published: 2016

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

DOI: https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Blood (2016) 128 (22): 5253.

DOI: https://doi.org/10.1182/blood.V128.22.5253.5253

Published: 2016

Journal Articles

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Blood (2016) 128 (22): 5432.

DOI: https://doi.org/10.1182/blood.V128.22.5432.5432

Published: 2016

Journal Articles

Secondary Adrenal Insufficiency Is Associated with Poor Survival Outcomes in Multiple Myeloma

Seo-Yeon Ahn, Sung-Hoon Jung, Hee Kyung Kim, Ho-Cheol Kang, Deok-Hwan Yang, Seung-Shin Lee, Jae-Sook Ahn, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee

Blood (2016) 128 (22): 5631.

DOI: https://doi.org/10.1182/blood.V128.22.5631.5631

Published: 2016

Journal Articles

The Clonal Origins of Leukemic Progression of Myelodysplasia

Taehyung Kim, MSc, Marc Tyndel, Hyeoung Joon Kim, MD, Jae-Sook Ahn, MD PhD, Seung Hyun Choi, PhD, Hee Jeong Park, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, Je-Jung Lee, Sung-Hoon Jung, Soo Young Kim, Yoo-Hong Min, June-Won Cheong, MD, Sang Kyun Sohn, MD, PhD, Joon Ho Moon, MD, PhD, Murim Choi, Moses Lee, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 4307.

DOI: https://doi.org/10.1182/blood.V128.22.4307.4307

Published: 2016

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

DOI: https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

Kyoung Ha Kim, Dae-Young Kim, MD PhD, Sung-Hyun Kim, Yeo-Kyeoung Kim, Inho Kim, Hee-Jin Kim, MD PhD, Sang Kyun Sohn, MD PhD, Jeon-Ok Lee, June-Won Cheong, MD, PhD, Chul Won Jung, MD PhD, Young-Uk Cho, MD PhD

Blood (2015) 126 (23): 5166.

DOI: https://doi.org/10.1182/blood.V126.23.5166.5166

Published: 2015

Journal Articles

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Taehyung Simon Kim, PhD, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD, PhD, Seung Hyun Choi, PhD, Hyeoung-Joon Kim, MD PhD, Moses Lee, Murim Choi, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 2596.

DOI: https://doi.org/10.1182/blood.V126.23.2596.2596

Published: 2015

Journal Articles

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Sung-Hoon Jung, MD PhD, Hee Kyung Kim, Seok Jin Kim, MD PhD, Seung-Shin Lee, MD, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, Kihyun Kim

Blood (2015) 126 (23): 5313.

DOI: https://doi.org/10.1182/blood.V126.23.5313.5313

Published: 2015

2 3 4 5

NARROW

Next-generation sequencing–based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse

Next Generation Sequencing (NGS)-Based Post-Transplant Monitoring in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Dynamics of Methylation Profiling in Response to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Clinical and Genetic Relevance of Somatic Mutations in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML) Patients Using Serial Sequencing

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Comparison of Peripheral Blood Stem Cell Mobilization with Etoposide or Cyclophosphamide in Patients with Multiple Myeloma

Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy

Prognostic Value of NCCN-IPI and Interim PET/CT Based on Visual Assessment in the Treatment of Peripheral T Cell Lymphomas

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Aside from the Allelic Burden of JAK2 -V617F, Acquisition of Mutations in Myeloid Gene Panel Is Associated with the Transformation of Myeloproliferative Neoplasm into Secondary AML

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Secondary Adrenal Insufficiency Is Associated with Poor Survival Outcomes in Multiple Myeloma

The Clonal Origins of Leukemic Progression of Myelodysplasia

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only